Tuesday | Wednesday | Wednesday (OnDemand) | Thursday | Friday
WEDNESDAY, DECEMBER 8, 2021
     
All times are CENTRAL Time
 
7:00 am - 8:30 am CT POSTER SESSION 1
 
7:00 am - 8:30 am CT  SPOTLIGHT POSTER DISCUSSION SESSIONS  

Spotlight Poster Discussion 1- Endocrine Resistance: Novel mechanisms and emerging new therapies

Spotlight Poster Discussion 2 - Insights to CDK4/6i resistance: Novel models and clinical/translational genomics

Spotlight Poster Discussion 3 - Targets in Triple Negative Breast Cancer

 
8:45 am - 11:30 am CT GENERAL SESSION 2
 
10:00 am - 5:00 pm CT   EXHIBITS  
11:30 am - 12:00 pm CT WILLIAM L. MCGUIRE MEMORIAL LECTURE
Olufunmilayo (Funmi) Olopade, MD, FASCO, FACP, OON
University of Chicago Medicine
Chicago, IL
 
12:00 pm - 1:00 pm CT  CAREER DEVELOPMENT FORUM sponsored by Eisai, Inc.  
  The session is open to early-career scientists, defined as graduate students, postdoctoral or clinical fellows, or medical students and residents, who are registered attendees of the 2021 SABCS. Space in the workshop is limited. Preregistration is not required. Limited to 120 participants; registrations will be accepted on a first-come, first-served basis and are free of charge. Badges are required and will be scanned at the door for registration. Attendees should be prepared to visit 3-4 tables during the session. Attendees will be asked to rotate tables every 20 minutes.  
12:00 pm - 2:00 pm CT SPECIAL SESSIONS  
 

Re-framing Leadership in Academic Breast Oncology post COVID-19
Co-Moderator: Carlos L. Arteaga, MD
UT Southwestern Medical Center
Simmons Comprehensive Cancer Center
Dallas, TX

Co-Moderator: Rebecca Dent, MD, MSc
National Cancer Center Singapore
Singapore, Singapore

Learning by leading- lessons learned
Clifford A. Hudis, MD, FACP, FASCO
American Society of Clinical Oncology
Alexandria, VA

Applying the lessons of my mentor to building a successful translational breast program
TBD

Panel Members:
Lisa A. Carey, MD, ScM, FASCO
University of North Carolina at Chapel Hill
Chapel Hill, NC

Charles M. Perou, PhD
University of North Carolina at Chapel Hill
Chapel Hill, NC

Eric P. Winer, MD
Dana-Farber Cancer Institute
Boston, MA

Kornelia Polyak, MD, PhD
Dana-Farber Cancer Institute
Boston, MA

 

Regulatory Insights to the 2021 Early Stage Breast Cancer Approvals
Moderator: Laleh Amiri Kordestani, MD
Food and Drug Administration
Silver Spring, MD

TBD
Christy Osgood, MD
Food and Drug Administration
Silver Spring, MD

TBD
Mirat Shah, MD
Food and Drug Administration
Silver Spring, MD

TBD
Melanie Royce, MD
Food and Drug Administration
Silver Spring, MD

TBD
Alberto Montero, MD
University Hospitals Seidman Cancer Center
Cleveland, OH

 

Health Equity in Translational Research Studies
Co-Moderator: Melissa L. Bondy, PhD
Stanford Medicine
Stanford, CA

Co-Moderator: Patty Spears
University of North Carolina at Chapel Hill
Chapel Hill, NC

Working with patient advocates to promote diversity in trial participation and biospecimen donation
Vernal Branch
UNC Chapel Hill Breast SPORE
Chapel Hill, NC

Increasing accrual of Latinos into clinical trials: A cancer center’s perspective
Amelie Ramirez, DrPH
UT Health San Antonio
San Antonio, TX

Engaging racial and ethnic minority women in clinical trials and biospecimen donation: Keeping it simple, strategic, and sincere
Vanessa B. Sheppard, PhD
Virginia Commonwealth University
Richmond, VA

Integrating community networks in cancer research to increase diversity in clinical trials accrual
Lidia Schapira, MD, FASCO
Stanford University School of Medicine
Stanford, CA

Supporting and infusing health equity in translational research at the investigator and organizational level
Melissa Simon, MD, MPH
Northwestern University
Chicago, IL 

 
2:00 pm - 3:00 pm  CT TRANSLATIONAL SCIENCE FORUM  
 

ER Mutations and SERDS
Moderator: Fabrice Andre, MD, PhD
Institut Gustave Roussy
Villejuif, France

Next generation sequencing in ER targets
Donald P. McDonnell, PhD
Duke University School of Medicine
Durham, NC

ER+ word salad decoded: SERD, SERM, SERCA, CERAN, PROTAC
Komal Jhaveri, MD
Memorial Sloan Kettering Cancer Center
New York, NY

  BASIC SCIENCE FORUM  

Targeting Nuclear Steroid Receptors
Moderator: Carol Lange, PhD
University of Minnesota
Minneapolis, MN

AR
Wayne Tilley, PhD
The University of Adelaide
Adelaide, Australia

PR
Christy R. Hagan, PhD
University of Kansas Medical Center
Kansas City, KS

GR
Suzanne Conzen, MD
UT Southwestern Medical Center
Dallas, TX

 

CASE DISCUSSIONS
 

Clinical Case Discussion
Moderator: Matthew P. Goetz, MD
Mayo Clinic
Rochester, MN

Panel Members
Thelma Brown
Boon Chua
Hope Rugo
Anne Vincent-Solomon
Lee Wilke 

 


 
3:00 pm - 5:00 pm CT  EDUCATIONAL SESSIONS
 

Triple Negative Breast Cancer: Critical Update on Biology and Management
Moderator: Rita Nanda, MD
University of Chicago
Chicago, IL

Genomic and transcriptomic landscape of TNBC
Zhi-Ming Shao, MD
Fudan University of Shanghai
Shanghai, China

Optimizing the management of early stage TNBC
Elizabeth A. Mittendorf, MD, PhD
Dana-Farber Brigham and Women's Cancer Center
Boston, MA

Management of special subtypes of TNBC
Alexandra Thomas, MD, FACP
Wake Forest Baptist Health
Winston-Salem, NC

 

Emerging Adjuvant Therapies: What's Ready for Prime Time?
Moderator: Angela DeMichele, MSCE
University of Pennsylvania
Philadelphia, PA

Approving new therapies
Suparna Wedam, MD
Food and Drug Administration
Silver Spring, MD

CDK4/6 for ER+
Ingrid A. Mayer, MD, MSCI
Vanderbilt-Ingram Cancer Center
Nashville, TN

IO vs Capecitabine for TNBC
Sherene Loi, MD, PhD
Peter MacCallum Cancer Centre
Melbourne, Australia

PARP for BRCA+ breast cancers
Andrew Tutt, MD
Institute of Cancer Research
London, United Kingdom

 

Fine Tuning Risk Assessment and Risk Reduction
Moderator: Banu Arun, MD
UT MD Anderson Cancer Center
Houston, TX

Lifestyle: Exercise and diet
Neil M. Iyengar, MD
Memorial Sloan Kettering Cancer Center
New York, NY

Emergent pharmacologic interventions for prevention: Non endocrine treatments
Brandy Heckman, PhD, MPH
National Cancer Institute
Rockville, MD

Imaging/AI
Constance Lehman, MD, PhD
Massachusetts General Hospital
Boston, MA

Panel Discussion
Ashley A. Dedmon

 

SABCS with the Society of Surgical Oncology present Local Therapy - Management of the Axilla
Moderator: Hiram (Chip) Cody, MD
Memorial Sloan Kettering Cancer Center
New York, NY

Axillary management in upfront surgery - staging, local control or both?
Stephanie Wong, MD, MPH
McGill University
Montreal, Canada

Refining axillary management after neoadjuvant chemotherapy - what does the evidence support
Eleftherios (Terry) Mamounas, MD, MPH, FACS
Orlando Health Cancer Institute
Orlando, FL

Can radiation replace ALND after + SLNB
Reshma Jagsi, MD, DPhil
University of Michigan
Ann Arbor, MI

Options for reducing risk for lymphedema when ALND/regional nodal XRT are needed
Hani Sbitany, MD
Mount Sinai
New York, NY

 
5:00 pm - 6:30 pm CT POSTER SESSION 2  
5:00 pm - 6:30 pm CT SPOTLIGHT POSTER DISCUSSIONS  

Spotlight Poster Discussion 4 - Brain Metastases: Managing LMD / Targeting HER2
Spotlight Poster Discussion 5 -  Life after breast cancer: Cardiac health, fertility preservation, and returning to life
Spotlight Poster Discussion 6 - Genomic and genetic analysis on metastases
 
     
7:30 pm - 10:00 pm CT

OPEN SATELLITE EVENTS 

 
     
 
Tuesday | Wednesday | Wednesday (OnDemand) | Thursday | Friday
 

S1-04.

S1-04.

Phase III study of trastuzumab emtansine (T-DM1) vs trastuzumab as adjuvant therapy in patients with HER2-positive early breast cancer with residual invasive disease after neoadjuvant chemotherapy and HER2-targeted therapy including trastuzumab: primary results from KATHERINE
Limited to 200 participants; registrations will be accepted on a first-come, first-served basis and are free of charge. Badges are required and will be scanned at door for registration.   Attendees should prepare to visit 3-4 tables during the session. Attendees will be asked to rotate tables every 20 minutes.
Limited to 200 participants; registrations will be accepted on a first-come, first-served basis and are free of charge. Badges are required and will be scanned at door for registration.   Attendees should prepare to visit 3-4 tables during the session. Attendees will be asked to rotate tables every 20 minutes.
Limited to 200 participants; registrations will be accepted on a first-come, first-served basis and are free of charge. Badges are required and will be scanned at door for registration.   Attendees should prepare to visit 3-4 tables during the session. Attendees will be asked to rotate tables every 20 minutes.
Tuesday | Wednesday | Wednesday (OnDemand) | Thursday | Friday
In collaboration with  Astro     and     SSO